OTCMKTS:VTXPF - Victrex Stock Price Target and Predictions

Target and Analyst Ratings
Price Target History
Upgrades and Downgrades
About
FAQ

Consensus Rating: Hold
Consensus Price Target: $0.00
Forecasted Upside: -100.00 %
Number of Analysts: 12
Breakdown:
2 Sell Ratings
3 Hold Ratings
7 Buy Ratings
0 Strong Buy Ratings

^$36.25 As of 06/18/2021 01:00 AM ET

+0.30 (1.20%)

1 month | 3 months | 12 months

Get New Victrex Analyst Ratings Delivered To Your Inbox

Sign-up to receive the latest news and ratings for VTXPF and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for VTXPF

^$0.00

▼ -100.00% Downside Potential

This price target is based on 12 analysts offering 12 month price targets for Victrex in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $36.25.

Current Consensus is Hold

The current consensus among 12 investment analysts is to hold stock in Victrex.

Past Monthly Recommendations

Move your mouse over past months for details Read Past Recommendations Description Skip Past Price Target Consensus Chart

0 strong buy ratings
0 buy ratings
0 hold ratings
0 sell ratings

Ratings as of

12/29/2019

0 strong buy ratings
1 buy ratings
0 hold ratings
1 sell ratings

Ratings as of

3/28/2020

0 strong buy ratings
2 buy ratings
2 hold ratings
1 sell ratings

Ratings as of

6/26/2020

0 strong buy ratings
2 buy ratings
2 hold ratings
2 sell ratings

Ratings as of

9/24/2020

0 strong buy ratings
5 buy ratings
3 hold ratings
2 sell ratings

Ratings as of

12/23/2020

0 strong buy ratings
5 buy ratings
3 hold ratings
2 sell ratings

Ratings as of

3/23/2021

0 strong buy ratings
7 buy ratings
4 hold ratings
2 sell ratings

Ratings as of

5/22/2021

0 strong buy ratings
7 buy ratings
3 hold ratings
2 sell ratings

Ratings as of

6/21/2021

Latest Recommendations

Show Most Recent Rating from Each Ratings Firm Show All Ratings

Date	Brokerage	Action	Rating
5/12/2021	Jefferies Financial Group	Reiterated Rating	Buy
5/12/2021	UBS Group	Reiterated Rating	Sell
5/11/2021	Credit Suisse Group	Reiterated Rating	Outperform
5/11/2021	JPMorgan Chase & Co.	Upgrade	Neutral ➝ Overweight
4/14/2021	UBS Group	Reiterated Rating	Sell
4/1/2021	Stifel Nicolaus	Upgrade	Hold ➝ Buy
3/30/2021	Citigroup	Upgrade	Sell ➝ Neutral
3/30/2021	Exane BNP Paribas	Upgrade	Neutral ➝ Outperform
2/24/2021	Barclays	Reiterated Rating	Equal Weight
2/5/2021	Morgan Stanley	Reiterated Rating	Underweight
12/15/2020	Berenberg Bank	Reiterated Rating	Hold
12/14/2020	Peel Hunt	Upgrade	Hold ➝ Buy
12/10/2020	UBS Group	Reiterated Rating	Sell
12/10/2020	Barclays	Upgrade	Underweight ➝ Equal Weight
12/1/2020	Barclays	Reiterated Rating	Underweight
10/7/2020	CSFB	Reiterated Rating	Outperform
10/7/2020	Credit Suisse Group	Reiterated Rating	Outperform
8/24/2020	Barclays	Reiterated Rating	Underweight
7/22/2020	Morgan Stanley	Reiterated Rating	Underweight
7/8/2020	UBS Group	Reiterated Rating	Sell
6/24/2020	Barclays	Reiterated Rating	Underweight
6/1/2020	Liberum Capital	Downgrade	Buy ➝ Hold
5/19/2020	Jefferies Financial Group	Initiated Coverage	Buy
5/7/2020	Barclays	Reiterated Rating	Underweight
3/30/2020	Morgan Stanley	Reiterated Rating	Underweight
3/24/2020	JPMorgan Chase & Co.	Reiterated Rating	Neutral
3/23/2020	Morgan Stanley	Reiterated Rating	Underweight

(Data available from 6/21/2016 forward)

Victrex plc, through its subsidiaries, manufactures and sells polymers worldwide. It offers PEEK and PAEK polymer materials; and specialist solutions for medical device manufacturers. It serves automotive, aerospace, energy, manufacturing and engineering, electronics, and medical markets. The company was incorporated in 1993 and is headquartered in Thornton Cleveleys, the United Kingdom.

Today's Range

Now: $36.25

$36.25

50 Day Range

MA: $33.31

$30.85

$36.25

52 Week Range

Now: $36.25

$23.75

$36.25

Volume

N/A

Average Volume

671 shs

Market Capitalization

$3.14 billion

P/E Ratio

37.76

Dividend Yield

N/A

Beta

1.29

Frequently Asked Questions

What sell-side analysts currently cover shares of Victrex?

The following sell-side analysts have issued reports on Victrex in the last twelve months: Barclays PLC, Berenberg Bank, Citigroup Inc., Credit Suisse Group AG, CSFB, Exane BNP Paribas, Jefferies Financial Group Inc., JPMorgan Chase & Co., Morgan Stanley, Peel Hunt, Stifel Nicolaus, UBS Group AG, and Zacks Investment Research.
View the latest analyst ratings for VTXPF.

What is the current price target for Victrex?

0 Wall Street analysts have set twelve-month price targets for Victrex in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for Victrex in the next year.
View the latest price targets for VTXPF.

What is the current consensus analyst rating for Victrex?

Victrex currently has 2 sell ratings, 3 hold ratings and 7 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in VTXPF, but not buy more shares or sell existing shares.
View the latest ratings for VTXPF.

What other companies compete with Victrex?

Other companies that are similar to Victrex include bioMérieux, Brambles, Renault, GN Store Nord A/S, Burberry Group, Covestro, Recordati Industria Chimica e Farmaceutica, MonotaRO, CapitaLand, Jerónimo Martins, SGPS, Air China, Davide Campari-Milano, Disco, Orient Overseas (International) and Nitto Denko.

How do I contact Victrex's investor relations team?

Victrex's physical mailing address is Hillhouse International Thornton Cleveleys, Lancashire X0, FY5 4QD. The company's listed phone number is 44-12-5389-7700 and its investor relations email address is [email protected] The official website for Victrex is www.victrexplc.com.